Drug Discovery Biology

Drug Discovery Biology February 27, 2025

The Druggable Proteome: A Paradox of Untapped Potential

The integration of chemoproteomics into early-stage discovery heralds a renaissance for pharmacology.

Drug Discovery Biology February 27, 2025

Decoding the Proteome: How Disorder and Dynamics Drive Cellular Complexity

The proteome’s complexity emerges from its intrinsic disorder—a paradox where fluidity begets precision.

Drug Discovery Biology February 20, 2025

Thermodynamic Ballet: Enthalpic-Entropic Compensation in Biomolecular Handshakes

Enthalpy-entropy compensation epitomizes the complexity of biomolecular recognition.

Drug Discovery Biology February 20, 2025

Structural Secrets of SRβ GTPase: Unlocking the Ancient Code of Eukaryotic Membrane Traffic

SRβ, the oldest Ras-family member, connects billion-year-old innovations to modern eukaryotic secretory processes through its structural simplicity and regulatory sophistication.

Drug Discovery Biology February 13, 2025

Selectivity Dilemma: Why AI Struggles to Design Highly Targeted GPCR Ligands

The study of GPCR selectivity through docking has illuminated both the power and the limitations of current AI-driven approaches.

Drug Discovery Biology February 6, 2025

Oncotherapeutic Transmutation: The Role of Organoid Drug Testing in Precision Medicine for Peritoneal Carcinomatosis

Organoids empower clinicians and researchers to transcend standardized treatments, enabling the customization of therapies to the specific biological traits of each patient’s tumor.

Drug Discovery Biology February 6, 2025

Brain in a Dish: A Novel Image Analysis Workflow for Cortical Organoids

Customized image analysis workflows integrate high-content imaging, machine learning, and computational tools to standardize and enhance the precision of brain organoid research.

Drug Discovery Biology January 23, 2025

Breathing New Life into Research: The Promise of Advanced Lung Organoids in Respiratory Disease Modeling

In the quest to understand and treat pulmonary diseases, lung organoids stand at the forefront, offering a window into the complexities of the respiratory system.

Drug Discovery Biology January 23, 2025

Oncopediatric Revolution: Advancing Therapeutic Insights with Fusion-Negative Rhabdomyosarcoma 3D Organoids

FNRMS-derived organoids may bridge the gap between bench and bedside, offering renewed hope for patients with this devastating disease.

Drug Discovery Biology January 9, 2025

Ion Transport Revolution: Investigating the Na+,K+-ATPase Mechanism and the Role of Ser777

The study of Ser777 mutants underscores the Na+,K+-ATPase as a model of molecular precision, balancing ion selectivity, and conformational flexibility.

Drug Discovery Biology December 19, 2024

Voltage-Gated Sodium Channels: The Hidden Engines of Breast Cancer Metastasis

Emerging evidence positions ion channels, specifically voltage-gated sodium channels (VGSCs), as crucial players in cancer progression.

Drug Discovery Biology December 19, 2024

The Dynamic Epitranscriptome: A New Frontier in RNA Biology

As detection methods improve, researchers are poised to uncover the full scope of RNA modifications and their roles in cellular physiology.

Drug Discovery Biology December 17, 2024

The Critical Role of NAC1: Driving Tumor Stemness and Immune Suppression in Triple-Negative Breast Cancer

Originally linked to neural responses and embryonic stem cell maintenance, NAC1 now occupies the spotlight for its multifaceted roles in oncogenesis.

Drug Discovery Biology December 16, 2024

Breaking the Barrier: Neutralizing GDF-15 to Combat Checkpoint Inhibitor Resistance in Solid Tumors

As clinical investigations progress, visugromab may redefine the therapeutic landscape for patients with refractory solid tumors.

Drug Discovery Biology December 10, 2024

Cellularized Polymeric Microarchitectures: The Future of Drug Screening and Xenobiotic Development

By mimicking the structural and functional complexity of living tissues, 3D cell culture systems better predict in vivo drug responses.

Drug Discovery Biology November 22, 2024

Unlocking Neural Gateways: The Complexity of CaV2.2 Voltage-Gated Calcium Channels

Voltage-gated calcium channels (VGCCs) are crucial for neuronal communication, with CaV2.2 channels playing a key role in calcium-driven neurotransmitter release.

Drug Discovery Biology November 20, 2024

Illuminating Life: The Frontier of Bioluminescent and Chemiluminescent Biosensors

The future of luminescent biosensors lies in their integration with emerging technologies, such as gene editing and optogenetics.

Drug Discovery Biology November 5, 2024

Unlocking Cellular Fate: The Science Behind Direct Reprogramming in Cellular Reprogramming

By leveraging the extraordinary potential of elite cells, scientists could revolutionize cellular reprogramming, paving the way for groundbreaking treatments for degenerative diseases, injuries, and even the aging process.

Drug Discovery Biology October 14, 2024

Powering Cellular Highways: From Kinesin Discovery to Pharmacological Prospects

Kinesins are not only transporters but also crucial regulators of mitosis

Drug Discovery Biology September 17, 2024

Rethinking Preclinical Models in Drug Discovery

The design of new preclinical models should carefully consider both their biological relevance and practical feasibility.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings

Inside Johnson & Johnson’s External Innovation Engine: Devin Swanson on Translating Integrated Discovery into Strategic Value

From Data to Decision: Shicheng Guo’s Systems Approach to AI-Enabled Drug Development

Digital Stewardship: Governing Access, Transparency, and Accountability in Clinical Data Warehouses